PUBLISHER: KBV Research | PRODUCT CODE: 1219855
PUBLISHER: KBV Research | PRODUCT CODE: 1219855
The Europe Electronic Data Capture Systems Market would witness market growth of 14.3% CAGR during the forecast period (2022-2028).
Many clinical research organizations (CROs) and pharmaceutical companies started using eClinical solutions so they could simplify and more efficiently run clinical trials remotely. This comprised the implementation of a system for managing clinical trials, electronic data capture technologies, electronic consent, virtual visits, remote monitoring, electronic clinical outcome evaluation, and analytics, amongst other things.
At the site or enterprise level, these systems were either deployed individually or as a complete all-in-one solution. In the midst of the pandemic, providers of EDC systems faced a number of issues, including the need to keep track of alternate approaches to making visits and to facilitate workflow in a way that could allow these other approaches. As a result, market participants started delivering adaptable solutions to meet customers' ever-evolving requirements.
In addition, technological advancements in healthcare equipment have led to an improvement in the quality of care that is offered to patients who are undergoing treatment for chronic ailments and the elderly population that is reliant on them. The revenue generated by the home healthcare market in the United Kingdom is expected to increase during the period covered by this forecast for a number of reasons, including the fact that patients will become more independent by decreasing their reliance on medical professionals, the fact that care will become of higher quality, that healthcare parameters will be monitored more closely, that it will be easier to access, and that it will cost less than institutional care.
The Germany market dominated the Europe Electronic Data Capture Systems Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $165.5 million by 2028.The UK market is anticipated to grow at a CAGR of 13.4% during (2022 - 2028). Additionally, The France market would exhibit a CAGR of 15.2% during (2022 - 2028).
Based on Component, the market is segmented into Services and Software. Based on End User, the market is segmented into CROs, Pharmaceutical & Biotechnology Firms, Hospitals/Healthcare providers, Medical Device Firms and Others. Based on Development Phase, the market is segmented into Phase III, Phase II, Phase I and Phase IV. Based on Delivery Mode, the market is segmented into Web & Cloud-based and On-premise. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Oracle Corporation, IBM Corporation, Veeva Systems, Inc., IQVIA Holdings, Inc., Medidata Solutions, Inc. (Dassault Systems SE), OpenClinica, LLC, DATATRAK International, Inc., Clario, Castor EDC, and Calyx.
Market Segments covered in the Report:
By Component
By End-user
By Development Phase
By Delivery Mode
By Country
Companies Profiled
Unique Offerings from KBV Research
List of Figures